Live feed
Filing
SC 13G
SC 13G0001829126-23-005443·Eiger BioPharmaceuticals, Inc.
Schedule 13G ownership disclosure
EIGER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 28249U105
Event date: 2023-08-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001829126-23-005443
- Form type
- SC 13G
- Filer
- Eiger BioPharmaceuticals, Inc.
- CIK
- CIK 1305253
- Filed
- Aug 15, 2023
- Reporting period
- Aug 02, 2023
- Description
- Schedule 13G beneficial ownership